Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
Sign In


Contact details

Allen & Overy LLP
One Bishops Square
E1 6AD
United Kingdom

Telephone icon+44 20 3088 3340
Send email

Download contact detailsDownload contact details View officeView office

  Matthew Appleton



Matthew is a Corporate/M&A Partner with a particular focus on the Life Sciences and the Consumer & Retail sectors. He has significant experience advising clients on a wide variety of matters, including private M&A, joint ventures, public takeovers, restructurings and listing requirements.

Matthew has specific expertise in highly complex cross-border M&A transactions. He regularly advises clients on M&A auction processes, executing successful transactions both for sellers and for buyers. "Excellent - pragmatic and thorough." - Legal 500

Experience includes advising:

Asahi on its USD11.3bn acquisition of Carlton & United Breweries, the Australian arm of Anheuser-Busch InBev.

Asahi Group on its EUR7.30bn acquisition of the Central & Eastern European business of SABMiller by way of auction.

Asahi Group on its EUR2.55bn acquisition of Peroni, Grolsch and Meantime by way of auction.

Grünenthal on its USD922m acquisition from AstraZeneca of prescription products Nexium in Europe and Vimovo worldwide (excluding the U.S. and Japan).

Life Healthcare Group Holdings on its GBP600m acquisition of Alliance Medical Group by way of auction.

Grünenthal on its acquisition of the global rights to the migraine medication, Zomig, from AstraZeneca for a total consideration of up to USD302m.

GlaxoSmithKline on the GBP1.35bn disposal of its nutritional drinks brands, Lucozade and Ribena, to Suntory Beverage & Food, the Japanese consumer goods company.

GlaxoSmithKline on various disposals of prescription and consumer healthcare products by way of auction.

US-headquartered global pharmaceutical company on its series A2 equity investment in a UK biotech company and related research/collaboration agreement in respect of certain antigen targets. 

G Square Healthcare Private Equity and Aribua on the sale of SARquavitae to PAI Partners.

SSL International on its recommended public takeover by Reckitt Benckiser for GBP2.54bn.

IMI on the USD1.1bn disposal of its beverage dispense and merchandising businesses to The Marmon Group, a Berkshire Hathaway company, and related return of cash to shareholders.

Tullett Prebon on its GPB1.4bn reverse takeover, carve-out acquisition of ICAP's global hybrid broking and information business and related issuance of consideration shares and readmission to the LSE.

TUI AG on its all-share merger with TUI Travel and related admission to the LSE.

MP & Silva and its shareholders on the sale of a majority stake in the business to Everbright and Beijing Baofeng Technology by way of auction.

Professional qualifications

Admitted as solicitor, England and Wales, 2009.

Academic qualifications

BA, Law, Magdalene College, Cambridge University, 2005.

Find a lawyer

  • Expertise

  • Search Clear

  • Add comment (optional)